Showing results (1291-1300 of 1,693) with videos related to

Sort By:
Pageof 170
Trends in Cancer|December 3, 2025
Mapping heterogeneity in the tumor microenvironment of renal cell carcinoma through single-cell omicsBetul Gok Yavuz, Narmina Khanmammadova, Zuhair Majeed, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Targeting tRNA-Arg-TCT-4-1 suppresses cancer cell growth and tumorigenesisEsteban A Orellana, Isobel E Bowles, Xin Yang, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2023
Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancersCody A Loy, Christine S Muli, Eslam M H Ali, et al.
International Journal of Phytoremediation|July 11, 2023
Biosorption of hexavalent chromium and molybdenum ions using extremophilic cyanobacterial mats: efficiency, isothermal, and kinetic studiesKhairia M Al-Qahtani, Mohamad S Abd Elkarim, Foziah F Al-Fawzan, et al.
Tropical Biomedicine|January 5, 2023
Steroids from Diplazium esculentum: Antiplasmodial activity and molecular docking studies to investigate their binding modesH F Safar, A H Ali, N H Zakaria, et al.
American Journal of Therapeutics|May 6, 2016
A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary CirrhosisMarina G Silveira, Andrea A Gossard, Alisha C Stahler, et al.
British Journal of Anaesthesia|November 1, 1988
Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracuriumH H Ali, J J Savarese, P B Embree, et al.
Tropical Biomedicine|February 22, 2021
Biological control of Phlebotomus papatasi larvae by using entomopathogenic nematodes and its symbiotic bacterial toxinsH A El-Sadawy, M Y Ramadan, K N Abdel Megeed, et al.
American Journal of Translational Research|February 10, 2018
Potassium bromate-induced kidney damage in rats and the effect of gum acacia thereonBadreldin H Ali, Mohammed Al Za'abi, Turan Karaca, et al.
Journal of Vitreoretinal Diseases|August 25, 2025
Low-Dose 0.01% Atropine Eye Drops for Symptomatic Vitreous Floaters: A Noninvasive, Safe, and Effective Therapeutic OptionJeanette Du, Osama Sabbagh, Brian K Do, et al.
Pageof 170